Business
Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026
SEATTLE, May 11, 2026--Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the first quarter 2026 on Wednesday, May 13, 2026 after market close. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss recent developments and highlights as well as the Company’s financial results.
About this update from Omeros Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":342,"url":"https://media.zenfs.com/en/business-wire.com/d3631543f4c5420bdbc69986758069b2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/wgPh5g1WCVDjXf_vUUyhXw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY4NA--/https://media.zenfs.com/en/business-wire.com/d3631543f4c5420bdbc69986758069b2","width":480,"height":342},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/q13mNmkPbDPrqyoaYvMHSw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTQ1Ng--/https://media.zenfs.com/en/business-wire.com/d3631543f4c5420bdbc69986758069b2","width":480,"height":342}},"lazy":false},{"type":"text","content":"SEATTLE, May 11, 2026--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the first quarter 2026 on Wednesday, May 13, 2026 after market close. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss recent developments and highlights as well as the Company’s financial results.","length":417,"tagName":"p"},{"type":"text","content":"Conference Call Details and Webcast Link Instructions","length":53,"tagName":"p"},{"type":"text","content":"To access the live webcast, please click here or visit the "Upcoming Events" section of the Investor Relations page of Omeros’ website.","length":145,"tagName":"p"},{"type":"text","content":"A replay of the call will be available for 90 days in the "Archived Events" section of the Investor Relations page of Omeros’ website.","length":144,"tagName":"p"},{"type":"text","content":"As Omeros continues to transition to a new earnings call platform (hosted by Q4 Inc.), please allow extra time to log in prior to the start of the call.","length":152,"tagName":"p"},{"type":"text","content":"About Omeros Corporation","length":24,"tagName":"p"},{"type":"text","content":"Omeros is an innovative biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for both large-market and orphan indications, with a focus on complement-mediated diseases, cancers, and addictive or compulsive disorders. Omeros’ lead complement inhibitor YARTEMLEA® (narsoplimab-wuug), which targets the lectin pathway’s effector ...